Advances in the molecular and serological diagnosis of invasive fungal infection in haemato‐oncology patients
Open Access
- 4 June 2004
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 126 (3) , 289-297
- https://doi.org/10.1111/j.1365-2141.2004.05031.x
Abstract
Current laboratory diagnostic methods for invasive fungal infection (IFI) in haemato-oncology patients are insensitive, resulting in late diagnosis and contributing to high mortality. In recent years, progress has been made in the development and evaluation of sensitive sero-diagnostic assays, including detection of genomic DNA sequences and fungal antigens, which aid in a rapid, early diagnosis of IFI. The sensitivity and specificity of the assays vary considerably between studies, highlighting the need to correlate serological results with conventional laboratory tests and clinical or radiological findings. As part of management protocols, these assays may help to confirm the diagnosis of suspected IFI; however, the impact on mortality from IFI may be greatest when they are used to screen high-risk patients. Persistently positive screening results could direct early aggressive antifungal therapy, guided further by radiological and microbiological findings combined with regular clinical review, while the excellent negative predictive value may allow treatment to be withheld in patients with antibiotic resistant neutropenic fever but no other signs of IFI. However, this pre-emptive approach requires evaluation in prospective randomized trials.Keywords
This publication has 86 references indexed in Scilit:
- Treatment with Piperacillin‐Tazobactam and False‐PositiveAspergillusGalactomannan Antigen Test Results for Patients with Hematological MalignanciesClinical Infectious Diseases, 2004
- False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐TazobactamClinical Infectious Diseases, 2004
- Increased Sensitivity of Mannanemia Detection Tests by Joint Detection of α- and β-Linked Oligomannosides during Experimental and Human Systemic CandidiasisJournal of Clinical Microbiology, 2004
- Polymerase Chain Reaction Detection ofAspergillusDNA in Experimental Models of Invasive AspergillosisThe Journal of Infectious Diseases, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropeniaBritish Journal of Haematology, 2000
- Early Detection ofAspergillusInfection after Allogeneic Stem Cell Transplantation by Polymerase Chain Reaction ScreeningThe Journal of Infectious Diseases, 2000
- Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic FluconazoleThe Journal of Infectious Diseases, 2000
- Effect of Immunosuppression and Amphotericin B on Aspergillus Antigenemia in an Experimental ModelThe Journal of Infectious Diseases, 1988
- Anti-Candida antibodies in patients with acute leukemiaThe American Journal of Medicine, 1971